T0	Participants 66 144	screening normally intelligent persons with pervasive developmental disorders.
T1	Participants 228 469	25 normally intelligent high-functioning pervasive developmental disorder (HPDD) patients (mean age, 24.2 years; 24 male, one female) and 215 controls (mean age, 30.4 years; 86 male, 129 female) randomly selected from the general population.